Filed Aug. 17, 2017

Serial No. 79219288

Registered Oct. 30, 2018

Registration No. 5,592,411

Class Pharmaceutical and veterinary products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; immunosuppression pharmaceutical and veterinary products; sanitary preparations for medical purposes; Biological preparations for clinical medical use intended for gene therapy and cell therapy; Clinical medical reagents used for gene therapy, genetic testing and diagnosis; Cellular preparations for medical, pharmaceutical or veterinary use for gene therapy and cell therapy; Gene therapy products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; Immunosuppression gene therapy products; 006; 018; 044; 046; 051; 052; 100; 101; 100; 101